Resources: GLP-1 Agonists Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes Safety of Semaglutide Once-Weekly Semaglutide in Adults with Overweight or Obesity Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Medication-Induced Gastroparesis: A Case Report Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASSCVOT design and baseline characteristics Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial Tirzepatide prevents neurodegeneration through multiple molecular pathways TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Biology of Incretins: GLP-1 and GIP GIP and GLP1, the two incretin hormones: Similarities and differences GLP-1, GIP and glucagon receptor poly-agonists: A new era in obesity pharmacotherapy
In the interaction with host intestinal tissues, the gut microbiota influences brain functions, and microbial dysbiosis has been implicated in brain disorders such as Alzheimers disease (AD) and neuropsychiatric conditions (Wang W
Consult with our team before starting any peptide protocol
doi: 10.1016/j.aanat.2021.151855 42 AlexiadouKCuencoJHowardJWewer AlbrechtsenN,JIlesanmiIKamockaAet al
It can help promote muscle growth and fat loss by boosting growth hormone levels, enhance recovery, improve sleep quality, and has anti-aging properties
It helps regulate appetite, fullness and blood sugar levels
.png)
